Obesity vaccines

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Human Vaccines & Immunotherapeutics

• Publication date

  2014-04-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.4161/hv.27537PMID 24365968PMCID PMC4896563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunization Against Active Ghrelin Using Virus-Like Particles for Obesity Treatment

  2013influential reference
• Ghrelin as a GH-releasing factor.

  2013cited by this paper
• Formulary Management of 2 New Agents: Lorcaserin and Phentermine/Topiramate for Weight Loss

  2013cited by this paper
• Secretion of Glucose-Dependent Insulinotropic Polypeptide in Patients With Type 2 Diabetes

  2013cited by this paper
• Effects of novel vaccines on weight loss in diet-induced-obese (DIO) mice

  2012cited by this paper
• Therapeutic Potential of Vaccines in the Management of Hypertension

  2012cited by this paper
• Oligoclonal antibody targeting ghrelin increases energy expenditure and reduces food intake in fasted mice.

  2012cited by this paper
• Lorcaserin: drug profile and illustrative model of the regulatory challenges of weight-loss drug development

  2011cited by this paper
• Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity.

  2011cited by this paper
• The Peptidic GHS-R antagonist [D-Lys(3)]GHRP-6 markedly improves adiposity and related metabolic abnormalities in a mouse model of postmenopausal obesity.

  2011cited by this paper
• Effect of oral immunization with pooled antigens derived from adipose tissue on atherosclerosis and obesity indices.

  2010cited by this paper
• Glucose and Weight Control in Mice with a Designed Ghrelin O-Acyltransferase Inhibitor

  2010cited by this paper
• An Acyl-Ghrelin-Specific Neutralizing Antibody Inhibits the Acute Ghrelin-Mediated Orexigenic Effects in Mice

  2009cited by this paper
• Ghrelin vaccination decreases plasma MCP-1 level in LDLR(-/-)-mice.

  2009cited by this paper
• Obesity treatment: novel peripheral targets.

  2009cited by this paper
• Forecasting the effects of obesity and smoking on U.S. life expectancy.

  2009cited by this paper
• Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications

  2009cited by this paper
• Immunodrugs: therapeutic VLP-based vaccines for chronic diseases.

  2009cited by this paper
• The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

  2009cited by this paper
• Lifestyle and pharmacological approaches to weight loss: efficacy and safety.

  2008cited by this paper
• Vaccination against GIP for the Treatment of Obesity

  2008cited by this paper
• Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice

  2008cited by this paper
• Inhibition of ghrelin O-acyltransferase (GOAT) by octanoylated pentapeptides

  2008cited by this paper
• Ghrelin: a new peptide regulating growth hormone release and food intake.

  2008cited by this paper
• The Epidemiology of Obesity and Gastrointestinal and Other Diseases: An Overview

  2008cited by this paper
• Surgical treatment of obesity.

  2008cited by this paper
• Role of ghrelin in the relationship between hyperphagia and accelerated gastric emptying in diabetic mice.

  2008cited by this paper
• Overweight and obesity in Portugal: national prevalence in 2003–2005

  2007cited by this paper
• Total ghrelin plasma level in patients with the restrictive type of anorexia nervosa.

  2007cited by this paper
• Long term pharmacotherapy for obesity and overweight: updated meta-analysis

  2007cited by this paper
• Long term pharmacotherapy for obesity and overweight: updated meta-analysis

  2007cited by this paper
• Active immunization against ghrelin decreases weight gain and alters plasma concentrations of growth hormone in growing pigs.

  2007cited by this paper
• Increase in Ghrelin Levels After Weight Loss in Obese Zucker Rats is Prevented by Gastric Banding

  2007cited by this paper
• The role of proopiomelanocortin (POMC) neurones in feeding behaviour

  2007cited by this paper
• Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss.

  2007cited by this paper
• Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.

  2007cited by this paper
• Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets

  2007cited by this paper
• Vaccination against weight gain

  2006cited by this paper
• Ghrelin neutralization by a ribonucleic acid-SPM ameliorates obesity in diet-induced obese mice.

  2006cited by this paper
• Energy Homeostasis and Gastric Emptying in Ghrelin Knockout Mice

  2006cited by this paper
• Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature.

  2006cited by this paper
• Treatment of Obesity Using GH

  2006cited by this paper
• Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents.

  2005cited by this paper
• Ghrelin: structure and function.

  2005cited by this paper
• Pharmacologic and Surgical Management of Obesity in Primary Care: A Clinical Practice Guideline from the American College of Physicians

  2005cited by this paper
• Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients.

  2005cited by this paper
• Anti-ghrelin Spiegelmer NOX-B11 inhibits neurostimulatory and orexigenic effects of peripheral ghrelin in rats

  2005cited by this paper
• Absence of ghrelin protects against early-onset obesity.

  2005cited by this paper
• Obestatin, a Peptide Encoded by the Ghrelin Gene, Opposes Ghrelin's Effects on Food Intake

  2005cited by this paper
• Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor.

  2004cited by this paper
• Surgery Decreases Long-term Mortality, Morbidity, and Health Care Use in Morbidly Obese Patients

  2004cited by this paper
• Bariatric Surgery Worldwide 2003

  2004cited by this paper
• Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats.

  2004cited by this paper
• Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference.

  2004cited by this paper
• Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance.

  2004cited by this paper
• Effects of ghrelin on the insulin and glycemic responses to glucose, arginine, or free fatty acids load in humans.

  2003cited by this paper
• Obesity in Adulthood and Its Consequences for Life Expectancy: A Life-Table Analysis

  2003cited by this paper
• High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist.

  2003cited by this paper
• Virus-Like Particles as a Modular System for Novel Vaccines

  2003cited by this paper
• Virus-like particles as immunogens.

  2003cited by this paper
• Food fails to suppress ghrelin levels in obese humans.

  2002cited by this paper
• Virus-derived tubular structure displaying foreign sequences on the surface elicit CD4+ Th cell and protective humoral responses.

  2002cited by this paper
• Insulin regulates plasma ghrelin concentration.

  2002cited by this paper
• The obesity epidemic: pathophysiology and consequences of obesity.

  2002cited by this paper
• Weight loss increases circulating levels of ghrelin in human obesity

  2002cited by this paper
• Medical and surgical options in the treatment of severe obesity.

  2002cited by this paper
• Purification and characterization of rat des-Gln14-Ghrelin,a second endogenous ligand for the growth hormone secretagogue receptor

  2002cited by this paper
• Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.

  2002cited by this paper
• Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options.

  2002cited by this paper
• RAPID COMMUNICATIONS: Mutations in the Preproghrelin/Ghrelin Gene Associated with Obesity in Humans

  2001cited by this paper
• The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis

  2001cited by this paper
• A role for ghrelin in the central regulation of feeding

  2001cited by this paper
• Ghrelin causes hyperphagia and obesity in rats.

  2001cited by this paper
• Ghrelin enhances appetite and increases food intake in humans.

  2001cited by this paper
• The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box

  2000cited by this paper
• Ghrelin induces adiposity in rodents

  2000cited by this paper
• Central nervous system control of food intake

  2000cited by this paper
• Purification and Characterization of Rat des-Gln14-Ghrelin, a Second Endogenous Ligand for the Growth Hormone Secretagogue Receptor*

  2000cited by this paper
• Ghrelin is a growth-hormone-releasing acylated peptide from stomach

  1999cited by this paper
• Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

  1998cited by this paper
• Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

  1998cited by this paper
• Functional GIP receptors are present on adipocytes.

  1998cited by this paper
• A new form of particulate single and multiple immunogen delivery system based on recombinant bluetongue virus-derived tubules.

  1996cited by this paper
• 3-D reconstruction of bluetongue virus tubules using cryoelectron microscopy.

  1992cited by this paper
• Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food.

  1991cited by this paper
• North American Association for the Study of Obesity

  1991cited by this paper
• Surgical treatment of obesity.

  1989cited by this paper

• Anticipatory in silico vaccine designing based on specific antigenic epitopes from Streptococcus mutans against diabetic pathogenesis

  2024cites this paper
• Current progress in the development of prophylactic and therapeutic vaccines

  2022cites this paper
• Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022

  2022cites this paper
• Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor

  2022cites this paper
• Focus on the Lymphatic Route to Optimize Drug Delivery in Cardiovascular Medicine

  2021cites this paper
• Natural Dietary and Medicinal Plants with Anti-Obesity Therapeutics Activities for Treatment and Prevention of Obesity during Lock Down and in Post-COVID-19 Era

  2021cites this paper
• Polyvalent therapeutic vaccine for type 2 diabetes mellitus: Immunoinformatics approach to study co-stimulation of cytokines and GLUT1 receptors

  2020cites this paper
• Obesity: the New Global Epidemic. Pharmacological Treatment, Opportunities and Limits for Personalized Therapy.

  2020cites this paper
• A review on the current drugs and new targets for obesity

  2020cites this paper
• Tratamento farmacológico da obesidade: passado, presente e futuro.

  2019cites this paper
• The continuing search for an addiction vaccine.

  2019cites this paper
• Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon

  2018cites this paper
• Recent Advances in the Development of Vaccines for Diabetes, Hypertension, and Atherosclerosis

  2018cites this paper
• Xanthine analogues and adipose tissue metabolism

  2017cites this paper
• The Importance of the Gastrointestinal Tract in Controlling Food Intake and Regulating Energy Balance.

  2017cites this paper
• Emerging Pharmacotherapies to Fight Obesity and Related Disorders

  2014cites this paper